Namliong SkyCosmos Inc の最大収益セグメントは Modernised Chinese Medicines and Chemical Medicines で、最新の利益発表における収益は 30,858,886,510 です。地域別に見ると、China が Namliong SkyCosmos Inc の主要市場であり、収益は 31,297,379,178 です。
Namliong SkyCosmos Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Namliong SkyCosmos Incの純損失は$0です。
Namliong SkyCosmos Incに負債はありますか?
いいえ、Namliong SkyCosmos Incの負債は0です。
Namliong SkyCosmos Incの発行済株式数は何株ですか?
Namliong SkyCosmos Incの総発行済株式数は0株です。
主要データ
前終値
$0.0001
始値
$0.0001
当日レンジ
$0.0001 - $0.0001
52週レンジ
$0.0001 - $0.0001
取引高
2.1K
平均取引高
8.6K
配当利回り
--
1株当たり利益(TTM)
-0.04
時価総額
$1.4K
NLSCとは何ですか?
Namliong SkyCosmos, Inc. engages in marketing and selling day spa services to tourist at resorts destination throughout Mexico. The company is headquartered in Tainan, Tainan. The company went IPO on 2006-08-22. The STT chemical process intensification system provides solutions to many of the manufacturing issues related to the production of chemicals. The firm has developed production units to manufacture biodiesel fuel based upon its STT technology. Its offerings include STT 30G biodiesel production unit, which is a complete, pipe-to-pipe biodiesel production system. In addition to its STT 30G, it also offers STT Reactor Systems and related plant engineering services for partnerships.